Application of Double Fluorescence in Situ Hybridization Technology in the Diagnosis of Bladder Urothelial Carcinoma

LIU Hong,ZHANG Yang-de,LIU Xing-yan,GAO Xin
DOI: https://doi.org/10.3969/j.issn.1005-8982.2010.10.012
2010-01-01
Abstract:[Objective]To evaluated the performance of a dual-color FISH (fluorescence in situ hybridization) assay for urothelial carcinoma (UC) of the bladder, in comparison to urinary cytology[.Methods]Fluorescence in situ hybridization (FISH) was performed using centromeric probes of chromosome 7, 9, 17 and 9p21 region to examine chromosome aberration of exfoliated cells in 78 urine samples from patients with urothelial carcinoma (UC) of the bladder, 30 urine samples from healthy control. All of the samples were analyzed by urinary cytology at the same time[.Results]The sensitivity of urine cytology for Ta, T1 and T2-T4 tumors was 35.5% (11/31), 54.1 %(13/24) and 69.6% (16/ 23), respectively, for an overall sensitivity of 51.6%. The sensitivity of FISH for Ta, T1 and T2-T4 tumors was 64.5% (20/31), 87.5% (21/24) and 95.7% (22/23), respectively, for an overall sensitivity of 80.8%. FISH was significantly more sensitive than cytology for T1 (P =0.047), T2-T4 (P =0.0235), grade Ⅱ (P =0.004), grade Ⅲ(P =0. 002) and all tumors (P =0.001). The specificity of cytology and FISH was 98% and 96%, respectively (P =0.612)[.Conclusion] The sensitivity of FISH for the detection urothelial carcinoma (UC) of the bladder is superior to that of cytology, and the specificity of FISH and cytology for urinary bladder cancer are not significantly different. FISH can improve significantly the diagnosis of urinary bladder cancer and will be significant for screening of urinary bladder cancer.
What problem does this paper attempt to address?